【レポートの概要（一部）】
1. Report Overview
1.1 Biobanking for Medicine: World Market Review 2015 and Global Segmentation
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction to Biobanking and its Applications
2.1 Defining the Human Tissue Banking Market for the Scope of this Report
2.2 The Stem Cell Banking Market – Our Breakdown
2.3 What is Biobanking?
2.4 Main Features of Biobanks
2.5 What Processes are Involved in Biobanking?
2.6 Classification of Biobanks: Tissue Type, Volunteer Group and Ownership Classification Models
2.6.1 Volunteer Group: General vs. Disease Population
2.6.2 Ownership Structure: Public vs. Private
2.7 The Guidelines and Standards for Biobanking
2.8 Laws and Regulations for Biobank-Based Research
2.8.1 HIPAA Amendments
2.9 Biobanking and the Pharmaceutical Industry
2.9.1 Biobanking in Research, Drug Discovery and Development
2.9.1.1 Biobanking – Facilitates Genetic Epidemiology Studies
2.9.1.2 Novel Drug Discovery through Better Understanding of Disease Pathways
2.9.1.3 Biomarker Discovery in Drug Development
2.9.2 Biobanking for Therapeutic Purposes
2.9.3 Biobanking in Clinical Trials
3. Biobanking for Medicine: World Market 2015 to 2026
3.1 The World Biobanking for Medicine Market in 2015
3.2 Biobanking for Medicine: Research vs. Therapeutics in 2020 and 2026
3.3 World Biobanking for Medicine Market: Overarching Revenue Forecast 2015 to 2026
3.4 Biobanks Stored More Than 1.4 Billion Specimens in 2015
3.5 The Biobanking for Medicine Market by Sector: Grouped Revenue Forecasts 2015 to 2026
3.6 Biobanking for Research: Mostly Non-Profit
3.6.1 Biobanking for Research: Revenue Forecast 2015 to 2026
3.6.2 Driving Forces: Outweighs Restraints on the Biobanking Industry for Research
3.7 Biobanking for Future Therapeutic Use: Is It Too Commercial?
3.7.1 Arguments against Commercial Stem Cell Banking for Therapeutic Uses
3.7.2 Biobanking for Future Therapeutic Use: Revenue Forecast 2015 to 2026
3.7.3 Driving and Restraining Forces Influencing the Biobanking Market for Therapeutic Applications, 2015 to 2026
4. Biobanking for Research Purposes
4.1 Breakdown of Biobanking for Research Market by Tissue Type, 2015
4.2 Biobanking for Research in 2020 and 2026: Comparison by Tissue Type
4.3 Biobanking for Research by Tissue Type: Grouped Revenue Forecasts 2015 to 2026
4.4 How Many Specimens are Biobanked for Research?
4.5 The Human Tissue Banking Market for Research in 2015
4.6 The Human Tissue Banking Market for Research: Revenue Forecast 2015 to 2026
4.7 The Human Tissue Banking Market: Commercial vs. Public Sectors
4.7.1 Commercial Human Tissue Banks: Revenue Forecast 2015 to 2026
4.7.2 Public Sector Human Tissue Banks: Revenue Forecast 2015 to 2026
4.8 The Stem Cell Banking Market for Research in 2015
4.9 The Stem Cell Banking Market for Research: Revenue Forecast 2015 to 2026
4.9.1 R&D- Growing Interest Towards iPSCs
4.10 Banking of Other Biologics Specimens for Research in 2015
4.11 Banking of Other Biologic Specimens for Research: Revenue Forecast 2015 to 2026
5. Stem Cell Banking for Future Therapeutic Use
5.1 Stem Cell Banking for Therapeutic Use in 2015: A Breakdown by Stem Cell Type
5.2 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Comparison of Revenue and Market Share, 2020 and 2026
5.3 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Grouped Revenue Forecasts
5.4 How Many Stem Cells Are Biobanked Each Year?
5.5 The Umbilical Cord Blood Banking Market in 2015
5.5.1 Private vs. Public Cord Blood Banking
5.5.2 Umbilical Cord Blood Banking: The Controversies
5.6 The Umbilical Cord Blood Banking Market: Revenue Forecast 2015 to 2026
5.7 The Adult Stem Cell Banking Market in 2015
5.8 The Adult Stem Cell Banking Market: Revenue Forecast 2015 to 2026
6. Leading National Markets 2015 to 2026
6.1 The Geographical Footprint of Biobanking
6.1.1 Biobanking in Europe: Leading the World with Biobanking Networks and Infrastructure
6.1.2 Biobanks in the US: A Fragmented Picture
6.1.3 Biobanking in Asia: A Region Fast Gaining Prominence
6.2 Biobanking for Medicine: The US Led the Way in 2015
6.3 The Leading National Markets: Grouped Revenue Forecasts 2015 to 2026
6.4 How Will Regional Market Shares Change to 2026?
6.5 The US Biobanking Market 2015 to 2026: Diversifying and Expanding
6.6 The Top European Biobanking Markets 2015 to 2026: Leading the Way in Biobanking Infrastructure
6.6.1 Germany: An Advanced Industry with 74 Biobanks Associated with the BBMRI
6.6.2 France: Restrictions on Private Stem Cell Banking Limit the Market
6.6.3 Italy: Is the Limited Private Stem Cell Banking Market Off-Set by Strong Biobanking Networks for Research?
6.6.4 UK: Limited Presence of Biobanking Networks
6.6.5 Spain: Controversy Between Private and Public Umbilical Cord Blood Banks
6.6.6 The Netherlands is Characterised by Comprehensive Biobanking Networks
6.7 The Japanese Biobanking Market 2015 to 2026: A High Level of Government Investment Drives Growth
6.8 The Biobanking Industry in the BRIC Countries: High Growth and Increasing Market Share between 2015 and 2026
6.8.1 The Chinese Biobanking Market 2015 to 2026: The High Rate of Growth Will Continue
6.8.2 The Indian Biobanking Market 2015 to 2026: Set to Become the Leading Market for Private Stem Cell Banking?
6.8.3 The Brazilian Biobanking Market 2015 to 2026: Will New Regulations Drive or Restrain the Market?
6.8.4 Russia: Ban on the Import and Export of Human Tissue and Genetic Information Restricts the Market, But Can This Be Overcome from 2015 to 2026?
7. Technology for Biobanking: Systems, Software, Consumables and Services Associated with Biobanking
7.1 The Biobanking-Associated Market: Overview
7.2 Systems Technology: Fully Automated Handling
7.2.1 Automated Liquid Handling Systems
7.2.2 Frozen Aliquoting: Patented Technology from CryoXtract
7.2.3 Automated DNA Isolation
7.3 Storage Technology: Sustainability, Easy Sample Tracking, and Added Security
7.3.1 Dry State, Room Temperature Storage Eliminates the Need for Expensive, Energy-Consuming Freezers
7.3.2 Ultra-Low Temperature Freezers: Is Their Use Declining?
7.3.3 Cryopreservation: Mechanical vs. Liquid/ Vapour Phase Nitrogen
7.3.4 Automated Storage and Retrieval Systems: Essential Technology
7.3.5 RFID and Tagging Technology: Advantages over Barcodes
7.4 Software for Biobanks
7.4.1 Laboratory Information Management System (LIMS): Unmet Needs in the Market Remain, Despite Recent Advances
7.4.2 LIMS Functions
7.5 Consumables: High Quality Required for Effective Sample Management
7.5.1 Addressing Sample Storage and Tracking Issues
7.6 Biobanking Services: Storage, Management and Transport of Biologic Samples for a Fee
8. Leading Companies in the Biobanking Market
8.1 The Differing Business Models of Biobanking Companies: Sourcing vs. Storing
8.2 Commercial Biobanks for Research Purposes in 2015
8.2.1 Tissue Solutions: A Virtual Biobank with a Global Presence
8.2.1.1 An Overview of the Products and Services Offered by Tissue Solutions
8.2.1.2 Banked Samples Occur in Many Formats
8.2.1.3 Prospective Tissue Collection for Hard-to-Find Samples
8.2.1.4 Fresh Samples from Surgical Resections are in High Demand
8.2.1.5 Freshly Isolated Human Cells are a Valuable Research Tool
8.2.1.6 FDA/ EMA Panel of Normal Tissues
8.2.1.7 Strengths, Capabilities and the Future Outlook for Tissue Solutions
8.2.2 Asterand Bioscience is now Part of Stemgent
8.2.2.1 Asterand’s Products and Services: XpressBANK, BioSpoke and PhaseZERO
8.2.2.2 The Future Outlook for Asterand
8.2.3 Biopta: Human Tissue Provider Now Acquired by Japanese Company ReproCELL
8.2.3.1 Services from Biopta: A Variety of Lab Services and Fresh Tissue Sample Procurement
8.2.3.2 The First Catalogue of Assays Based on Human Functional Tissues
8.2.3.3 The Future Outlook for Biopta: Fresh Tissue Will Be in Demand
8.2.4 BioServe: One of the World’s Largest Commercial Biorepositories
8.2.4.1 BioServe Offers a Comprehensive List of Services: Biobanking, Sourcing and Preclinical Molecular Services
8.2.4.2 The Future Outlook for BioServe
8.2.5 Coriell Institute for Medical Research: Reportedly the Largest Biobank in the World
8.2.5.1 Features of and Recent Developments at Coriell Biobank
8.2.5.2 Future Outlook for the Coriell Biobank
8.3 Prominent Biobanks for Therapeutic Use in 2015
8.3.1 Cord Blood America: Expansion into the Emerging Markets Apparently Stalled, Strategic Alternatives Being Considered
8.3.2 Cryo-Cell International: The First Private Cord Blood Bank in the Market
8.3.3 Cryo-Save’s Educational Programme Benefits Company’s Growth
8.3.4 China Cord Blood Corp: The Only Cord Blood Bank in China with Multiple Licences Is Under a New Owner
8.3.5 LifebankUSA: Acquisition from Human Longevity Inc Will Potentially Drive Growth
8.3.6 ViaCord: More Blood Units Released for Therapy than Any Other Family Bank
8.3.7 Cord Blood Registry: The World’s Largest Newborn Stem Cell Company Will Be Promoted By New Parent Company
8.3.8 Biogenea Pharmaceuticals: A Comprehensive Offering of Stem Cell Banking Services across the Balkan Peninsula
8.3.9 StemLife is Reportedly Facing Challenges Due to Government Regulations in Malaysia
8.3.10 Future Health Biobank: A Strong Market Presence Owing to International Operations
8.3.11 Caladrius Biosciences (formerly NeoStem): More Focus on Cell Therapy Than Stem Cell Banking
8.3.12 Precious Cells is Well Positioned to Take Advantage of the Growing Demand in India
9. Qualitative Analysis of the Biobanking Market 2015 to 2026
9.1 Industry Trends
9.1.1 The Growing Demand for Biobank Resources for Research
9.1.2 The Establishment of Biobanking Networks
9.1.2.1 BBMRI: The Most Extensive Biobank Network
9.1.3 Virtual Biobanks: Connecting a Fragmented Industry
9.1.4 Commercial Biobanks as Intermediaries: New Resources for Research
9.1.5 Automated Biobanking Has Become Imperative
9.1.6 Increasing Uptake of LIMS
9.1.7 Green Banking – Becoming More Energy Efficient
9.2 The Strengths and Weaknesses of the Biobanking Market in 2015
9.2.1 HBS are Valuable Resources for R&D
9.2.2 Governmental Support for Biobanking Forms a Strength of that Industry
9.2.3 Development of Potential Novel Stem Cell Therapies has Increased Public Awareness of Stem Cell Banking
9.2.4 The Effect of Big Data on Biobanking
9.2.5 Insufficient Accessible Numbers of High Quality Biospecimens
9.2.6 Biobanks are Fragmented and Uncoordinated
9.2.7 Lack of Standardisation is a Weakness of the Industry
9.2.8 Lack of Public Awareness Limits Number of Donors
9.2.9 Lack of Engagement with Public Health Services Limits the Stem Cell Banking Market
9.3 Opportunities and Threats Facing the Biobanking Market, 2015 to 2026
9.3.1 Increasing Use of Biobanked Specimens in Genome-Wide Association Studies (GWAS)
9.3.2 Increasing Demand for Biobanked Samples for Preclinical Research
9.3.3 Biobanking Networks as a Basis for Personalised Medicine
9.3.4 Options for Adult Stem Cell Banking Mean an Increasing Target Population for Private Stem Cell Banks
9.3.5 Even With Governmental Funding, Biobanks Must Become Self-Sufficient to Thrive Long-Term
9.3.6 Public Concerns over Confidentiality and Security Threaten Availability of Donors
9.3.7 Limitations Surrounding Informed Consent
9.4 Social, Technological, Economic and Political Factors (STEP) Influencing the Biobanking Industry, 2015 to 2026
10. Research Interviews
10.1 Mr Veselin D. Stefanov, MBA, General Manager, Fidelis Research, Bulgaria
10.1.1 Fidelis Research – Specialists in Human Tissue Procurement With a Strong Network of Partners
10.1.2 Challenges in Tissue Procurement Stem from a Lack of Legislation
10.1.3 Lack of Standardisation Causing Decreased Demand for Biobanked Tissues
10.1.4 Significant Therapeutic Areas of Demand
10.1.5 Essential Qualities for a Successful Tissue Procurement Service
10.1.6 The Impact of Trends in Biobanking
10.2 Dr Jeanne-Hélène di Donato, 3C-R, France
10.2.1 French Biobanks – a Network of Specialized Biobanks
10.2.2 Biobanking Management –Promoting Scientific Value of Collections
10.2.3 Harmonization – Scientific Valorisation
10.2.4 Bioethical – Diverse Views and Policies on Consent
10.2.5 Broad Consent –Is This the Best Option?
10.2.6 3C-R – Services and Solutions for Biobanks
10.3 Dr Luis Nacul and Dr Eliana Lacerda, UK ME/CFS Biobank Project
10.3.1 UK ME/CFS Biobank – Objectives and Activities
10.3.2 Biobank Resource – Available for External Researchers in August 2015
10.3.3 Main Issue – Sustainability
10.3.4 Unmet Needs – Awareness from Government and General Public
11. Conclusions from Our Research and Analysis
11.1 World Biobanking Market 2015 to 2026: High Revenue Growth Predicted
11.2 Biobanking for Research 2015 to 2026: The Value of Biobanked Specimens is Increasingly Recognised
11.3 Biobanking for Therapeutic Use 2015 to 2026: Rapid Expansion in Adult Stem Cell Banking
11.4 The Leading National Markets: High Sales Growth Worldwide
11.5 Current and Future Trends in Biobanking
11.5.1 Increasing Demand for Biobanked Samples – Increasing Revenue
11.5.2 Improving Biobanking Infrastructure – Growth Driver and a Need for Strategic Planning for Sustainability
11.5.3 Marked Challenges, but Opportunities for Expansion
【レポート販売概要】
■ タイトル：バイオバンクの世界市場予測2016-2026■ 英文：Biobanking Market Forecasts 2016-2026
■ 発行日：2016年4月
■ 調査会社：visiongain
■ 商品コード：VGAIN60628
■ 調査対象地域：グローバル
- 世界のミサイル及びミサイル防衛システム市場：市場規模及びドライバーSynopsis This report provides readers with a comprehensive analysis of the Missiles and Missile Defense Systems market through 2014-2024, including highlights of the demand drivers and growth stimulators for Missiles and Missile Defense Systems. It also provides an insight on the spending pattern and modernization pattern in different regions around the world. Summary The global missiles and missi …
- 世界のRFコンポーネント市場動向（2012-2016）TechNavio's analysts forecast the Global Radio Frequency (RF) Components market to grow at a CAGR of 12.5 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing government regulatory norms. The Global Radio Frequency Components market has also been witnessing rapid technological advancement. However, the production of RF components requires c …
- 世界における小型自動車用OE(メーカー純正部品)コネクティビティ（ネットワーク接続）市場動向と予測（～2029）This latest just-auto report edition offers a global review of the OE connected vehicle sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE connected vehicle market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies …
- 世界の遠隔患者モニタリング市場動向（2014-2018）About Remote Patient Monitoring Remote patient monitoring is a technology that enables the monitoring of patients outside clinics and hospitals. Remote patient monitoring provides a remote interface that gathers and transfers regular patient monitoring data between a home-based patient and the remotely located care provider. By using these devices patients can play a more central role in managing …
- αケトグルタル酸の世界市場Alpha Ketoglutaric Acid (CAS 328-50-7) Market Research Report 2013 presents comprehensive data on alpha-ketoglutaric acid markets globally and regionally (Europe, Asia, North America etc.) The Alpha Ketoglutaric Acid (CAS 328-50-7) Market Research Report 2013 includes alpha-ketoglutaric acid description, covers its application areas and related patterns. It overviews alpha-ketoglutaric acid market …
- ミニエクスカベーター（小型掘削機）の世界市場ABSTRACTAbout Mini Excavators Mini excavators are compact hydraulic excavators with undercarriage or wheels made from either rubber or steel, and have an operating range of 0.75 ton to 10 ton. These excavators feature a standard bucket and backfill blade along with independent boom swing. Mini excavators are used in small to medium-sized operations such as light construction work, forestry work, l …
- スコットランドの再生可能エネルギー産業分析：Analyzing Renewable Energy Industry in ScotlandScotland is utilizing its abundant renewable resources to the greatest potential. Scotland is known across the world for its beautiful landscapes and dynamic renewable energy industry and the Scottish Government has to balance both of these priorities. The oil, gas and renewable energy sectors make a significant contribution to the Scottish economy and provide substantial opportunities for investm …
- ガスエンジンの世界市場予測（～2021年）：天然ガス、特殊ガス、発電、熱電併給The global gas engines market is projected to grow at a CAGR of 6.9% from 2016 to 2021, to reach a market size of USD 4.54 Billion by 2021. This growth is attributed to the drop in natural gas prices and growing environmental concerns across the globe. The report segments the gas engines market on the basis of end-user industry into utilities, oil & gas, manufacturing, and others. Others include c …
- 過活動膀胱治療法の世界市場2019-2023Global Overactive Bladder Therapeutics Market: About this market Technavio’s overactive bladder (OAB) therapeutics market analysis considers sales from anticholinergics. Beta-3 adrenergic agonists, and other OAB therapeutics. Our analysis also considers the sales of overactive bladder therapeutics in Asia, Europe, North America, and ROW. In 2018, the anticholinergics segment had a significant mark …
- 世界の高性能自動販売機市場動向（2012-2016）TechNavio's analysts forecast the Global Intelligent Vending Machines market to grow at a CAGR of 45.5 percent over the period 2012-2016. One of the key factors contributing to this market growth is the improved user interface of intelligent vending machines. The Global Intelligent Vending Machines market has also been witnessing rapid technological advancement. However, the increasing cost of ren …
- パーキンソン病治療薬の世界市場2016-2026Parkinson’s Diseases: World Drug Industry and Market 2016-2026 – our new study reveals trends, R&D progress, and predicted revenues Our new report discusses issues and events affecting the Parkinson’s disease therapeutics market. Our new report provides qualitative analyses to answer these key questions: • How is the Parkinson’s disease therapeutics market evolving? • What is driving and restraini …
- 贋金検出の世界市場：偽札鑑別機、通貨処理機The overall counterfeit money detection market is expected to reach USD 3.11 Billion by 2020, growing at a CAGR of 6.9% between 2015 and 2020. The growth of this market is propelled by initiatives taken by various governments to implement the counterfeit money detectors to prevent the circulation of fake currency. The growing number of fraudulent activities and transaction of fake currency across …
- チオフェン誘導体の世界市場Thiophenes (CAS 14282-76-9) Market Research Report 2013 presents comprehensive data on thiophenes markets globally and regionally (Europe, Asia, North America etc.) The Thiophenes (CAS 14282-76-9) Market Research Report 2013 includes thiophenes description, covers its application areas and related patterns. It overviews thiophenes market, names thiophenes producers and indicates its suppliers. Bes …
- アクリル酸メチルの世界市場The global methyl acrylate market is estimated to grow at a CAGR of 4.3% between 2014 and 2019. Asia-Pacific held the largest share of the methyl acrylate market, while the North American market is expected to grow at the highest CAGR of 3.8% during the forecast period of 2014 to 2019. In this report, the global methyl acrylate market has been classified on the basis of application and geography. …
- World Insecticides Market Dynamics and Trends 2014: Strategic Assessments of Leading SuppliersThis new report from Venture Planning Group analyzes marketing strategies of the world’s leading agrochemical companies. The report was prepared by Venture Planning Group to provide agrochemical industry executives with strategically significant competitor information, analysis and insight, critical to the development and implementation of effective marketing and R&D programs. In a highl …
